Victory Capital Management Inc. Sells 24,666 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Victory Capital Management Inc. lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 604,951 shares of the healthcare conglomerate’s stock after selling 24,666 shares during the quarter. Victory Capital Management Inc.’s holdings in UnitedHealth Group were worth $353,703,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. China Universal Asset Management Co. Ltd. grew its stake in shares of UnitedHealth Group by 20.6% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after purchasing an additional 1,857 shares during the period. Quent Capital LLC lifted its stake in shares of UnitedHealth Group by 5.5% during the 1st quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after acquiring an additional 217 shares during the last quarter. Koshinski Asset Management Inc. lifted its stake in shares of UnitedHealth Group by 49.5% during the 1st quarter. Koshinski Asset Management Inc. now owns 8,708 shares of the healthcare conglomerate’s stock worth $4,308,000 after purchasing an additional 2,883 shares during the last quarter. WP Advisors LLC lifted its position in UnitedHealth Group by 5.7% during the first quarter. WP Advisors LLC now owns 4,858 shares of the healthcare conglomerate’s stock valued at $2,403,000 after acquiring an additional 263 shares during the last quarter. Finally, Miramar Capital LLC raised its holdings in shares of UnitedHealth Group by 2,089.5% in the first quarter. Miramar Capital LLC now owns 21,698 shares of the healthcare conglomerate’s stock worth $10,870,000 after buying an additional 20,707 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $7.29 during mid-day trading on Tuesday, hitting $617.96. 894,501 shares of the company were exchanged, compared to its average volume of 3,888,270. The company has a market capitalization of $568.70 billion, a P/E ratio of 40.73, a PEG ratio of 1.81 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The business’s 50 day simple moving average is $582.63 and its two-hundred day simple moving average is $546.78.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the previous year, the company posted $6.56 earnings per share. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio is 54.72%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on UNH shares. KeyCorp began coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 target price on the stock. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 24th. Finally, Royal Bank of Canada lowered their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.